Post-transplant lymphomas: A 20-year epidemiologic, clinical and pathologic study in a single center

Haematologica

Volumn 86, Issue 7, 2001, Pages 715-721

  Domingo Domenech E ^a   De Sanjose S ^a   Gonzalez Barca E ^a   Romagosa, V ^a   Domingo Claros A ^a   Gil Vernet, S ^a   Figueras, J ^a   Manito, N ^a   Oton B ^a   Petit, J ^a   Granena A ^a   Fernandez de Sevilla A ^a  

^a NONE   (Spain)

Author keywords

Epstein Barr virus; Immunosuppression; Post transplant lymphomas

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACARBAZINE; DOXORUBICIN; OKT 3; PREDNISONE; PROCARBAZINE; THYMOCYTE ANTIBODY; VINCRISTINE SULFATE;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; EPSTEIN BARR VIRUS; FEMALE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; RISK FACTOR;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; LYMPHOMA; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; SURVIVAL RATE;

EID: 0034912406     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Incidence of tumors in organ transplants
2. Lymphomas in solid organ transplantation
3. Patterns of malignancies following renal transplantation
4. Clinical characteristics of post-transplant lymphoproliferative disorders
5. Diagnosis and treatment of transplant-related lymphoma
6. The role of EBV in post-transplant malignancies: A review
7. Postransplant lymphoproliferative disease following renal transplantation: A multicenter retrospective study of 41 cases observed between 1992 and 1996
8. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin
9. Viral etiology of human cancer: A historical perspective
10. Epstein-Barr virus lymphoproliferative disorders after liver transplantation
11. Post-transplant T-cell lymphoproliferative disorders: An aggressive, late complication of solid-organ transplantation
12. Epstein-Barr virus infection
13. Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center
14. Epstein-Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney, and liver transplant
15. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: A distinct entity?
16. The pathology of liver-localized post-transplant lymphoproliferative disease: A report of three cases and a review of the literature
17. Post-transplant lymphoproliferative disorder localized near the allograft in renal transplantation
18. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients
19. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients
20. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: A report of three cases
21. Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients